Cartesian Therapeutics Inc (RNAC)
Working Capital Ratio
41.76%
Quarterly · Period ending:
RNAC Working Capital Ratio
Latest reported41.76%period ending
Latest reported41.76%period ending
RNAC Quarterly Working Capital Ratio (73.84% → 41.76%)
Quarterly working capital ratio
High-resolution chart · PNG
RNAC working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 41.7619% | |
| 36.7882% | |
| 38.5745% | |
| 35.8106% | |
| 38.8639% | |
| 41.5814% | |
| 44.5149% | |
| 45.6235% | |
| 28.3739% | |
| 22.8946% | |
| 7.3824% | |
| 65.9505% | |
| 66.9204% | |
| 71.8472% | |
| 74.1841% | |
| 76.2623% | |
| 73.8079% | |
| 62.2948% | |
| 45.153% | |
| 33.5914% | |
| 44.0478% | |
| 44.4242% | |
| 42.1894% | |
| 49.4475% | |
| 51.2486% | |
| 49.964% | |
| 61.9912% | |
| 16.794% | |
| 26.7131% | |
| 42.3834% | |
| 15.5838% | |
| 34.7065% | |
| 74.8179% | |
| 81.3614% | |
| 86.7527% | |
| 87.5204% | |
| 80.7733% | |
| 78.7776% | |
| 81.8692% | |
| 88.2582% | |
| 87.7252% | |
| 67.8772% | |
| 73.8441% |